BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oremus M, Don-Wauchope A, McKelvie R, Santaguida PL, Hill S, Balion C, Booth R, Brown JA, Ali U, Bustamam A, Sohel N, Raina P. BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure. Heart Fail Rev 2014;19:471-505. [PMID: 24986335 DOI: 10.1007/s10741-014-9439-6] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 Muñoz MA, Calero E, Duran J, Navas E, Alonso S, Argemí N, Casademunt M, Furió P, Casajuana E, Torralba N, Farre N, Abellana R, Verdú-Rotellar JM, On Behalf Of Hades Study. Short-Term Mortality in Patients with Heart Failure at the End-of-Life Stages: Hades Study. J Clin Med 2022;11:2280. [PMID: 35566406 DOI: 10.3390/jcm11092280] [Reference Citation Analysis]
2 Sakamoto D, Sakamoto S, Kanda T. Validation of circulating BNP level >1000 pg/ml in all-cause mortality: A retrospective study. J Int Med Res 2015;43:583-91. [DOI: 10.1177/0300060515583077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
3 Kasahara S, Sakata Y, Nochioka K, Tay WT, Claggett BL, Abe R, Oikawa T, Sato M, Aoyanagi H, Miura M, Shiroto T, Takahashi J, Sugimura K, Teng TK, Miyata S, Shimokawa H. The 3A3B score: The simple risk score for heart failure with preserved ejection fraction - A report from the CHART-2 Study. Int J Cardiol 2019;284:42-9. [PMID: 30413304 DOI: 10.1016/j.ijcard.2018.10.076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
4 Hedwig F, Nemchyna O, Stein J, Knosalla C, Merke N, Knebel F, Hagendorff A, Schoenrath F, Falk V, Knierim J. Myocardial Work Assessment for the Prediction of Prognosis in Advanced Heart Failure. Front Cardiovasc Med 2021;8:691611. [PMID: 34222382 DOI: 10.3389/fcvm.2021.691611] [Reference Citation Analysis]
5 Arzilli C, Aimo A, Vergaro G, Ripoli A, Senni M, Emdin M, Passino C. N-terminal fraction of pro-B-type natriuretic peptide versus clinical risk scores for prognostic stratification in chronic systolic heart failure. Eur J Prev Cardiol 2018;25:889-95. [PMID: 29569494 DOI: 10.1177/2047487318766580] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
6 Hobbs FR, Hussain RI, Vitale C, Pinto YM, Bueno H, Lequeux B, Pauschinger M, Obermeier M, Ferber PC, Gustafsson F; PREFER investigators. PRospective Evaluation of natriuretic peptide-based reFERral of patients with chronic heart failure in primary care (PREFER): a real-world study. Open Heart 2021;8:e001630. [PMID: 34670830 DOI: 10.1136/openhrt-2021-001630] [Reference Citation Analysis]
7 Lee J, McMillan R, Skiadopoulos L, Bansal V, Biller J, Hoppensteadt D, Fareed J. Circulating Biomarker Levels in Patients With Stage 5 Chronic Kidney Disease With Respect to Neurovascular Diseases. Clin Appl Thromb Hemost 2018;24:314S-22S. [PMID: 30428695 DOI: 10.1177/1076029618811090] [Reference Citation Analysis]
8 Ostovaneh MR, Moazzami K, Yoneyama K, A Venkatesh B, Heckbert SR, Wu CO, Shea S, Post WS, Fitzpatrick AL, Burke GL, Bahrami H, Sanchez OA, Daniels LB, Michos ED, Bluemke DA, Lima JAC. Change in NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Level and Risk of Dementia in Multi-Ethnic Study of Atherosclerosis (MESA). Hypertension 2020;75:316-23. [PMID: 31865797 DOI: 10.1161/HYPERTENSIONAHA.119.13952] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Schnorbach J, Fröhlich H, Täger T, Corletto A, Katus HA, Frankenstein L. N-terminal pro brain natriuretic peptide eliminates the prognostic effect of atrial fibrillation in patients with chronic heart failure. ESC Heart Fail 2019;6:640-8. [PMID: 31259484 DOI: 10.1002/ehf2.12464] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Janssen E, Jukema JW, Beeres SLMA, Schalij MJ, Tops LF. Prognostic Value of Natriuretic Peptides for All-Cause Mortality, Right Ventricular Failure, Major Adverse Events, and Myocardial Recovery in Advanced Heart Failure Patients Receiving a Left Ventricular Assist Device: A Systematic Review. Front Cardiovasc Med 2021;8:699492. [PMID: 34307507 DOI: 10.3389/fcvm.2021.699492] [Reference Citation Analysis]
11 Chen SN, Cheng CC, Tsui KH, Tang PL, Chern CU, Huang WC, Lin LT. Hypertensive disorders of pregnancy and future heart failure risk: A nationwide population-based retrospective cohort study. Pregnancy Hypertens 2018;13:110-5. [PMID: 30177036 DOI: 10.1016/j.preghy.2018.05.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
12 Park WY, Park S, Kim YW, Jin K. Clinical efficacy of biomarkers for evaluation of volume status in dialysis patients. Medicine (Baltimore) 2020;99:e21460. [PMID: 32756167 DOI: 10.1097/MD.0000000000021460] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Koracevic GP. Are we consistent in using 14 different units for brain natriuretic peptide instead of ng/L? Am J Emerg Med 2016;34:750-1. [PMID: 26897708 DOI: 10.1016/j.ajem.2016.01.031] [Reference Citation Analysis]
14 Don-wauchope AC, Mckelvie RS. Evidence based application of BNP/NT-proBNP testing in heart failure. Clinical Biochemistry 2015;48:236-46. [DOI: 10.1016/j.clinbiochem.2014.11.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
15 Vieira JL, Guimaraes GV, de Andre PA, Cruz FD, Saldiva PH, Bocchi EA. Respiratory Filter Reduces the Cardiovascular Effects Associated With Diesel Exhaust Exposure: A Randomized, Prospective, Double-Blind, Controlled Study of Heart Failure: The FILTER-HF Trial. JACC Heart Fail 2016;4:55-64. [PMID: 26738952 DOI: 10.1016/j.jchf.2015.07.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
16 Xu Y, Li Y, Bao W, Qiu S. Protective effects of recombinant human brain natriuretic peptide in perioperative period during open heart surgery. Exp Ther Med 2018;15:2869-73. [PMID: 29456690 DOI: 10.3892/etm.2018.5750] [Reference Citation Analysis]
17 Wang L, He Y, Zhang Y, Zhou H, Yu L, Yang J, Wan H. Effects of Active Components of Fuzi and Gancao Compatibility on Bax, Bcl-2, and Caspase-3 in Chronic Heart Failure Rats. Evid Based Complement Alternat Med 2016;2016:7686045. [PMID: 28053643 DOI: 10.1155/2016/7686045] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
18 Wong EKC, Lee JY, Leong DP, Mbuagbaw L, Yousuf H, Keen S, Straus SE, Patterson CJ, Demers C. Thiamine versus placebo in older heart failure patients: study protocol for a randomized controlled crossover feasibility trial (THIAMINE-HF). Pilot Feasibility Stud 2018;4:149. [PMID: 30258648 DOI: 10.1186/s40814-018-0342-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Li M, Gao X, Wang H, Zhang M, Li X, Wang S, Wang S, Cao C, Li Y, Su G. Phosphoglycerate mutase 2 is elevated in serum of patients with heart failure and correlates with the disease severity and patient's prognosis. Open Med (Wars) 2021;16:1134-42. [PMID: 34435138 DOI: 10.1515/med-2021-0324] [Reference Citation Analysis]
20 Li J, Cui Y, Huang A, Li Q, Jia W, Liu K, Qi X. Additional Diagnostic Value of Growth Differentiation Factor-15 (GDF-15) to N-Terminal B-Type Natriuretic Peptide (NT-proBNP) in Patients with Different Stages of Heart Failure. Med Sci Monit 2018;24:4992-9. [PMID: 30019695 DOI: 10.12659/MSM.910671] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
21 Arias-Barrera C, Palacios-Ariza MA, Pradilla I, Alvarez-Moreno C. A cohort study of two intravenous treatments for iron deficiency in patients with heart failure. Acta Cardiol 2019;:1-8. [PMID: 31298975 DOI: 10.1080/00015385.2019.1639270] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Wang J, Guo C, Li H, Zhao X, Zhao S. Prognostic value of NT-proBNP in Patients with Successful PCI for ACS and Normal Left Ventricular Ejection Fraction. The American Journal of the Medical Sciences 2022. [DOI: 10.1016/j.amjms.2021.10.017] [Reference Citation Analysis]
23 Zhu Q, Xiao W, Bai Y, Ye P, Luo L, Gao P, Wu H, Bai J. The prognostic value of the plasma N-terminal pro-brain natriuretic peptide level on all-cause death and major cardiovascular events in a community-based population. Clin Interv Aging 2016;11:245-53. [PMID: 27013868 DOI: 10.2147/CIA.S98151] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
24 Lu X, Zhang L, Wang J, Liu H, Li H, Zhou H, Wu R, Yang Y, Wen J, Wei S, Zhou X, Zhao Y, Xiao X. Clinical Efficacy and Safety of Xinmailong Injection for the Treatment of Chronic Heart Failure: A Meta-Analysis. Front Pharmacol 2018;9:810. [PMID: 30140225 DOI: 10.3389/fphar.2018.00810] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
25 Cao ZQ, Yu X, Leng P. Research progress on the role of gal-3 in cardio/cerebrovascular diseases. Biomed Pharmacother 2021;133:111066. [PMID: 33378967 DOI: 10.1016/j.biopha.2020.111066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Yamamoto S, Yamaga T, Nishie K, Sakai Y, ishida T, Oka K, Ikegami S, Horiuchi H. Impact of physical performance on prognosis among patients with heart failure: Systematic review and meta-analysis. Journal of Cardiology 2020;76:139-46. [DOI: 10.1016/j.jjcc.2020.02.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
27 Berezin AE, Kremzer AA, Martovitskaya YV, Samura TA, Berezina TA. The predictive role of circulating microparticles in patients with chronic heart failure. BBA Clin 2015;3:18-24. [PMID: 26672475 DOI: 10.1016/j.bbacli.2014.11.006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
28 Ma M, Luo Q, Dong X, Cui S, Hocher B, Zeng S, Liang W, Li Q, Chen X, Chen X, Meng Y, Lu Y, Yang D, Yin L. N-terminal prohormone B-type natriuretic peptide variability acts as a predictor of poor prognosis in patients with cardiorenal syndrome type 2. Bioengineered 2021;12:12407-19. [PMID: 34905428 DOI: 10.1080/21655979.2021.2005219] [Reference Citation Analysis]
29 Huang B, Shen J, Li L, Huang Y, Luo S. Effect of B-Type Natriuretic Peptide Level on Long-Term Outcome in Patients With End-Stage Heart Failure. Am J Cardiol 2016;118:383-8. [PMID: 27269584 DOI: 10.1016/j.amjcard.2016.05.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
30 Aleksova A, Beltrami AP, Carriere C, Barbati G, Lesizza P, Perrieri-Montanino M, Isola M, Gentile P, Salvioni E, Not T, Agostoni P, Sinagra G. Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy. Oncotarget 2017;8:25131-40. [PMID: 28212578 DOI: 10.18632/oncotarget.15349] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
31 Hedwig F, Soltani S, Stein J, Schoenrath F, Potapov E, Knosalla C, Falk V, Knebel F, Knierim J. Global work index correlates with established prognostic parameters of heart failure. Echocardiography 2020;37:412-20. [PMID: 32077524 DOI: 10.1111/echo.14612] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
32 Ohashi N, Takase H, Aoki T, Matsuyama T, Ishigaki S, Isobe S, Fujikura T, Kato A, Yasuda H. Salt intake causes B-type natriuretic peptide elevation independently of blood pressure elevation in the general population without hypertension and heart disease. Medicine (Baltimore) 2021;100:e25931. [PMID: 34106662 DOI: 10.1097/MD.0000000000025931] [Reference Citation Analysis]
33 Lee JW, Choi E, Khanam SS, Son JW, Youn YJ, Ahn MS, Ahn SG, Kim JY, Lee SH, Yoon J, Yoo BS. Prognostic value of short-term follow-up B-type natriuretic peptide levels after hospital discharge in patients with acute myocardial infarction. Int J Cardiol 2019;289:19-23. [PMID: 30638981 DOI: 10.1016/j.ijcard.2019.01.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
34 Chen YS, Gi WT, Liao TY, Lee MT, Lee SH, Hsu WT, Chang SS, Lee CC. Using the galectin-3 test to predict mortality in heart failure patients: a systematic review and meta-analysis. Biomark Med 2016;10:329-42. [PMID: 26860036 DOI: 10.2217/bmm.15.121] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
35 Berezin AE, Kremzer AA, Martovitskaya YV, Berezina TA, Samura TA. The utility of biomarker risk prediction score in patients with chronic heart failure. Clin Hypertens 2015;22:3. [PMID: 26973794 DOI: 10.1186/s40885-016-0041-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
36 Zhang A, Yang L, Guo P, Li S, Ao X, Xu F, Tan L. B-type brain natriuretic peptide as a measure of the severity of hand-foot-mouth disease: a case-control study. BMC Infect Dis 2017;17:651. [PMID: 28962547 DOI: 10.1186/s12879-017-2734-9] [Reference Citation Analysis]
37 Bai J, Sun H, Xie L, Zhu Y, Feng Y. Detection of cardioembolic stroke with B-type natriuretic peptide or N-terminal pro-BNP: a comparative diagnostic meta-analysis. International Journal of Neuroscience 2018;128:1100-8. [DOI: 10.1080/00207454.2017.1408612] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
38 Hedman ÅK, Hage C, Sharma A, Brosnan MJ, Buckbinder L, Gan L, Shah SJ, Linde CM, Donal E, Daubert J, Mälarstig A, Ziemek D, Lund L. Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning. Heart 2020;106:342-9. [DOI: 10.1136/heartjnl-2019-315481] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
39 Mishra RK, Judson G, Christenson RH, Defilippi C, Wu AH, Whooley MA. The Association of Five-Year Changes in the Levels of N-Terminal Fragment of the Prohormone Brain-Type Natriuretic Peptide (NT-proBNP) with Subsequent Heart Failure and Death in Patients with Stable Coronary Artery Disease: The Heart and Soul Study. Cardiology 2017;137:201-6. [DOI: 10.1159/000466682] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
40 Yamamoto S, Yamaga T, Sakai Y, Ishida T, Nakasone S, Ohira M, Ota E, Mori R. Association between physical performance and cardiovascular events in patients with coronary artery disease: protocol for a meta-analysis. Syst Rev 2016;5:32. [PMID: 26892852 DOI: 10.1186/s13643-016-0206-8] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
41 Kazukauskiene N, Burkauskas J, Macijauskiene J, Mickuviene N, Brozaitiene J. Exploring potential biomarkers associated with health-related quality of life in patients with coronary artery disease and heart failure. European Journal of Cardiovascular Nursing 2018;17:645-51. [DOI: 10.1177/1474515118772828] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
42 Bakos Z, Chatterjee NC, Reitan C, Singh JP, Borgquist R. Prediction of clinical outcome in patients treated with cardiac resynchronization therapy - the role of NT-ProBNP and a combined response score. BMC Cardiovasc Disord 2018;18:70. [PMID: 29699498 DOI: 10.1186/s12872-018-0802-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
43 De Giorgi A, Marra AM, Iacoviello M, Triggiani V, Rengo G, Cacciatore F, Maiello C, Limongelli G, Masarone D, Perticone F, Filardi PP, Paolillo S, Mancini A, Volterrani M, Vriz O, Castello R, Passantino A, Campo M, Modesti PA, Salzano A, D'Assante R, Arcopinto M, Raparelli V, Fabbian F, Sciacqua A, Colao A, Suzuki T, Bossone E, Cittadini A; T.O.S.CA. Investigators. Insulin-like growth factor-1 (IGF-1) as predictor of cardiovascular mortality in heart failure patients: data from the T.O.S.CA. registry. Intern Emerg Med 2022. [PMID: 35445917 DOI: 10.1007/s11739-022-02980-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Takagi S, Machida Y, Kobata T, Sakamoto D, Sakamoto S, Kanda T. Log-transformed B-type natriuretic peptide as a prognostic predictor in patients undergoing cardiovascular surgery. J Int Med Res 2018;46:4934-44. [PMID: 30426812 DOI: 10.1177/0300060518809238] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Zhang J, Pellicori P, Pan D, Dierckx R, Clark A, Cleland J. Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure. International Journal of Cardiology 2018;269:196-200. [DOI: 10.1016/j.ijcard.2018.06.070] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
46 Alawieh H, Chemaly TE, Alam S, Khraiche M. Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors. Sensors (Basel) 2019;19:E5003. [PMID: 31744130 DOI: 10.3390/s19225003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
47 Yoshitomi R, Nakayama M, Sakoh T, Fukui A, Shikuwa Y, Tominaga M, Tsuchihashi T, Tsuruya K, Kitazono T. Plasma B-type natriuretic peptide concentration is independently associated with kidney function decline in Japanese patients with chronic kidney disease. Journal of Hypertension 2016;34:753-61. [DOI: 10.1097/hjh.0000000000000847] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
48 Chahal D, Yau A, Casciato P, Marquez V. B-type peptides to predict post–liver transplant mortality: systematic review and meta-analysis. CanLivJ 2019;2:4-18. [DOI: 10.3138/canlivj.2018-0014] [Reference Citation Analysis]
49 Ni S. Effect of l-arginine on cardiac reverse remodeling and quality of life in patients with heart failure. Clin Nutr 2021;40:4653. [PMID: 34229271 DOI: 10.1016/j.clnu.2021.05.019] [Reference Citation Analysis]
50 Jones E, Wei J, Nelson MD, Bakir M, Mehta PK, Shufelt C, Minissian M, Sharif B, Pepine CJ, Handberg E, Cook-Wiens G, Sopko G, Bairey Merz CN. N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study. PLoS One 2020;15:e0243213. [PMID: 33270715 DOI: 10.1371/journal.pone.0243213] [Reference Citation Analysis]
51 Ohashi N, Takase H, Aoki T, Ishigaki S, Iwakura T, Isobe S, Fujikura T, Kato A, Yasuda H. Positive relationships between annual changes in salt intake and plasma B-type natriuretic peptide levels in the general population without hypertension and heart diseases. Hypertens Res 2022. [PMID: 35422510 DOI: 10.1038/s41440-022-00914-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
52 Harańczyk M, Konieczyńska M, Płazak W. Endothelial dysfunction in obstructive sleep apnea patients. Sleep Breath 2021. [PMID: 33961199 DOI: 10.1007/s11325-021-02382-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Berezin A, Zulli A, Kerrigan S, Petrovic D, Kruzliak P. Predictive role of circulating endothelial-derived microparticles in cardiovascular diseases. Clin Biochem 2015;48:562-8. [PMID: 25697107 DOI: 10.1016/j.clinbiochem.2015.02.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 7.4] [Reference Citation Analysis]
54 Schmid J, Stojakovic T, Zweiker D, Scharnagl H, Maderthaner RD, Scherr D, Maier R, Schmidt A, März W, Binder JS, Rainer PP. ST2 predicts survival in patients undergoing transcatheter aortic valve implantation. Int J Cardiol 2017;244:87-92. [PMID: 28651919 DOI: 10.1016/j.ijcard.2017.06.066] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
55 Kasahara S, Sakata Y, Nochioka K, Yamauchi T, Onose T, Tsuji K, Abe R, Oikawa T, Sato M, Aoyanagi H, Miura M, Shiroto T, Takahashi J, Miyata S, Shimokawa H; On behalf of the CHART-2 Investigators. Comparable prognostic impact of BNP levels among HFpEF, Borderline HFpEF and HFrEF: a report from the CHART-2 Study. Heart Vessels 2018;33:997-1007. [DOI: 10.1007/s00380-018-1150-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
56 Schoonbeek RC, Pieper PG, van Slooten YJ, Freling HG, Sieswerda GT, van Dijk AP, Jongbloed MR, Post MC, Bouma BJ, Berger RM, Ebels T, van Melle JP. NT-proBNP and exercise capacity in adult patients with congenital heart disease and a prosthetic valve: a multicentre PROSTAVA study. Neth Heart J 2016;24:653-65. [PMID: 27620913 DOI: 10.1007/s12471-016-0896-5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]